U.S. Markets close in 4 hrs 31 mins

Twitter, Inc. (TWTR)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
38.11+0.67 (+1.79%)
As of 11:29AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close37.44
Bid38.11 x 1100
Ask38.10 x 800
Day's Range37.43 - 38.27
52 Week Range20.00 - 45.86
Avg. Volume22,248,501
Market Cap29.902B
Beta (5Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)-1.58
Earnings DateOct 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.51
  • Twitter pledges to dial up efforts to combat election misinformation
    Editor's Pick

    Twitter pledges to dial up efforts to combat election misinformation

    In the latest sign of US platforms bracing for the 2020 US presidential election in November, Twitter has said it will step up efforts to prevent its service from being used to target voters with false information around election participation. Earlier today Facebook announced the launch of a voting hub aimed at combating election misinformation on its platform by gathering together genuine election resources. Twitter is spinning a bolder message -- saying its aim is to "empower every eligible person to register and vote" by working to surface accurate information.

  • Bloomberg

    Covid Spread Can’t Only Be Explained by Who’s Being ‘Bad’

    (Bloomberg Opinion) -- There are some weird things going on in the coronavirus data. It’s curious that cases dropped so fast, and have stayed pretty low, in the spring hot zones — New York, New Jersey and Connecticut. And why did cases remain so low in Idaho and Hawaii until recently?The mainstream narrative is that it’s all about good behavior when cases go down — mask wearing and giving up our social lives for the greater good. And conversely, bad behavior must be what makes them go up. We talk about certain regions having the virus “under control,” as if falling cases are purely a matter of will-power. A sort of moral reasoning is filling in for evidence.But why, then, have cases plummeted in Sweden, where mask wearing is a rarity?This is the time to use scientific methods to understand what’s happening. The pandemic has gone on long enough to reveal patterns in the way it spreads. If it’s all about behavior, that’s a testable hypothesis. If, as a few speculate, dramatic drops in some places have something to do with growing immunity in the population, we can also turn that into a testable hypothesis.“The issue with data is one can manipulate it to show anything you want if you have an agenda,” says YouYang Gu, an independent data scientist. Cherry picking is easy — prediction is much harder, and Gu is getting some attention for the fact that models he’s been creating since April actually forecast what’s happened with the spread of the disease in the U.S.He recently took to Twitter to urge public health officials to apply scientific thinking. He pointed to data on Louisiana, where cases were rising earlier in the summer and seemed to level off after various counties issued mask mandates.But breaking the data down by county, he says, revealed a different story. Mask mandates varied in their timing, but places that implemented them late saw no more cases or deaths than those that did so early. “I don’t think there’s currently enough evidence to support the fact that recent policy interventions (mask mandates, bar closures) were the main drivers behind the recent decrease in cases,” he wrote.That’s not to say that individual behavior doesn’t matter a lot — and the cancellation of big gatherings and other potential super-spreading events is more important than ever — but there may be more factors than we know driving the bigger picture.A few scientists are examining the possibility that previously hard-hit areas are now being affected by a buildup of immunity, even if it flies in the face of the widespread understanding that the disease has to run through at least 60% of the population to achieve so-called herd immunity. (So far, antibody tests show only some 10-20% of the U.S. population has had the disease.)The term herd immunity is a little vague in this context. It was created to characterize the impact of immunization. It refers to the percentage of the population that must get immunized in order for a pathogen to die out — a quantity that depends on the nature of the virus, the efficacy of the vaccine and the behavior of the hosts. If natural immunity is starting to help in some places, that would suggest herd immunity is a reasonable and worthy goal of an immunization program.But scientists have little experience applying herd immunity to a natural infection, and what understanding they have is changing. Scientists have started to investigate the possibility that there’s another critical factor here — heterogeneity in the way humans interact, and in our inherent, biological susceptibility to this disease.In a Science paper published in June, University of Stockholm mathematician Tom Britton and colleagues calculated that herd immunity might be reached after as few as 43% of a very heterogenous population becomes infected. People mix unevenly in a way that could lead to  little pockets of immunity, slowing the spread of the virus long before the world achieves herd immunity.We may also be heterogeneous in our biology. A recent paper in Science suggests that many people who’ve never been infected with SARS-CoV-2 carry a kind of immune cell, called a T-cell, which recognizes this novel virus and may partially mitigate an infection. These cells may be left over from infections with related viruses — the coronaviruses that cause the common cold.While scientists who authored the paper warn that it doesn’t imply that people with pre-existing T-cells can’t get infected, they leave open the possibility that it might account for some of the vast variability in symptoms.Whatever the source of this heterogeneity, we know it exists. Most people on the contaminated cruise ship Diamond Princess remained uninfected, while others got asymptomatic infections and still others got severely ill.Those differences can inform disease models, says statistics professor Gabriela Gomes of the University of Strathclyde in Scotland. “What we see is that infections do not occur at random, but that people who are most susceptible to infection get exposed first,” she says, leaving a pool of ever-less susceptible people behind.So far, her predictions of the spread in the U.K., Belgium, Spain and Portugal have aligned well with reality. Her models showed small, shallow second peaks that would concentrate away from the places where the pandemic was most rampant last spring. For example, in Spain, the first outbreak was around Madrid, and now a smaller outbreak is happening around Catalonia.She says her models keep predicting declines after the infection reached between 10% and 35% of the population. That doesn’t mean the virus has gone away — only that by her models, it won’t explode in those same places again. Gu’s models, too, predict no big second waves in New York City or Stockholm, but leave open the possibility of new outbreaks in relatively unaffected areas, just as Hawaii is now fighting outbreaks and New Zealand has imposed a new, short lockdown.She says she didn’t expect to come up against resistance to her models in the scientific community. While she’s starting to get some attention in the media, she said journal editors told her that her modeling ideas, in preprint, posed the danger of making people feel entitled to relax their vigilance. Maybe the opposite is true, she suggests. Maybe censoring all but the most pessimistic views could discourage action by making the problem seem endless.The controversy mirrors one that took place a few years ago when renowned cancer researcher Bert Vogelstein dared to suggest that the very nature of cancer had a random element and therefore some people who did everything right would get cancer through bad luck. He was pilloried for the view, not because it was untrue, but because it was deemed a dangerous invitation for people to be bad.Public health in the United States has a tendency toward moralizing against indulgences. We were told obesity was caused by indulgence in high-fat food even though the evidence pointed elsewhere, and it took years to recognize that opioid addiction is a disease and not a sin. That attitude may be ingrained in the culture, but it shouldn’t get in the way of the search for the truth.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Faye Flam is a Bloomberg Opinion columnist. She has written for the Economist, the New York Times, the Washington Post, Psychology Today, Science and other publications. She has a degree in geophysics from the California Institute of Technology.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Boeing-Airbus Trade Dispute Is a Pointless Relic

    Boeing-Airbus Trade Dispute Is a Pointless Relic

    (Bloomberg Opinion) -- The long-running trade dispute between Boeing Co. and Airbus SE has been a source of political grandstanding for years, but with the U.S.’s aggression reaching new levels of hypocrisy, the time may finally be right for a settlement. The U.S. Trade Representative’s office announced late Wednesday that it was leaving tariffs on $7.5 billion of imports because the European Union had not yet taken enough action to comply with a World Trade Organization ruling on illegal subsidies for Airbus. The U.S. is taking certain products from Greece and the U.K. off the list of items subject to the duties and adding an equal amount of goods from France and Germany, apparently to focus the pressure for a deal on those two countries. But the U.S. refrained from making good on a threat to impose tariffs on $3.1 billion of additional goods like olives and gin and increase existing duties on aircraft, wine and cheese. The U.S. “is committed to obtaining a long-term resolution to this dispute,” Robert Lighthizer, the trade representative, said in a statement, which called the tariff adjustments “modest.” Washington’s decision to hold off on increasing tariffs may help avoid the kind of escalation of tensions that would derail further talks. A European Commission post on Twitter called for both sides to “build on this decision and intensify their efforts to find a negotiated solution.”Let’s hope so. It’s unclear what justification the U.S. has for keeping the the tariffs in place at all. The question of who gave what aid many years ago feels a little silly when the pandemic has crippled air travel and forced governments on both sides to bend over backward to protect their aerospace industries from collapse. The crux of the U.S. trade complaint against Airbus was that the company depended on low-interest government loans to launch its A350 wide-body jet and the now-discontinued A380 superjumbo plane. Airbus said last month that it would amend the terms of the aid to comply with the WTO’s rulings, but Lighthizer has indicated he also wants the EU to somehow pay back the subsidy. It’s a curious stand to take considering that an unprecedented Federal Reserve bond-buying program is all that kept Boeing from having to give the government a direct equity stake in exchange for a lifeline. The planemaker has been clear that a $25 billion debt sale in April wouldn’t have happened without the Fed’s support of the credit markets and the willingness of Congress and the Treasury Department to extend $88 billion in aid to airlines, contractors, airports and aerospace suppliers. “We believe that government support will be critical to ensuring our industry’s access to liquidity,” Boeing Chief Executive Officer Dave Calhoun said in late April.  The continuation of the tariffs may be the U.S.’s way of clinging to whatever negotiating chips it still has, but it feels as if the White House has misjudged this situation. A counterclaim from the EU over U.S. aid to Boeing is still before the WTO, with a ruling expected as early as September on allowable retaliatory tariffs. Airbus said in a statement that it “profoundly regrets” the U.S. decision to maintain tariffs on aircraft and that it “trusts that Europe will respond appropriately to defend its interests.” Historically, criticism of the Boeing-Airbus dispute has centered on the risk of mutually assured destruction. But the reality now is that Boeing is much closer to the brink than Airbus. Boeing in February lent its support to legislation that would roll back the Washington State tax breaks ruled illegal by the WTO in an apparent realization that any EU tariffs would come at an inopportune time. If it only knew what lay in store. The grounding of the company’s marquee 737 Max jet in the wake of two fatal crashes is now coming up on a year and a half. That has loosened the restrictions on cancellations, making the plane a much easier cut for struggling airlines than comparable Airbus orders. Customers have now canceled or swapped orders for 416 Max jets so far this year, Boeing said this week. The company can’t afford to give customers yet another reason to back out in the form of tariffs. Not to mention the EU has yet to say when the Max will be allowed to return to its skies at all, giving it significant leverage over Boeing’s future cash-flow prospects. At best, approval from EU regulators is likely to come several months after the Federal Aviation Administration signs off, and any additional delay would further complicate the plane’s attractiveness in international markets.Meanwhile, a bipartisan group of 13 senators this week urged the U.S to roll back the tariffs on European food and beverages, warning of the hit to U.S. restaurants, grocers and consumers from higher prices and potential knock-on effects for agricultural exporters. The U.S.’s tough stance may backfire in more ways than one. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.